Skip to main content
. 2004 Sep 3;101(37):13624–13629. doi: 10.1073/pnas.0405499101

Fig. 1.

Fig. 1.

Comparison of various parameters in ACS-transgenic mice treated with AdCMV-leptin (ACS-Lep) or AdCMV-β-gal (ACS-β-gal) and untreated wild-type controls. (A) Mean (±SEM) plasma leptin level at 14 weeks of age (8 weeks after AdCMV treatments). (B) Mean (±SEM) food intake for the three groups. (C) Mean (±SEM) body weight for the three groups of mice. *, P < 0.01.